Abstract
The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Current Pharmaceutical Analysis
Title: Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization
Volume: 5 Issue: 2
Author(s): Luc J. Nagels, Bert Vissers, Hugo Bohets, Joseph Everaert and Johan Robbens
Affiliation:
Abstract: The miniaturization of potentiometric sensors is developing only slowly. ISFET technology has not yet brought great breakthroughs in this respect. Potentiometric microelectrode arrays are developed however for DNA analysis. As potentiometry moves into new and unexpected applications such as biomolecules, multiply charged molecules, DNA, marker proteins, viruses and bacteria, dissolution testing..., the need for miniaturized sensors and arrays will grow. Possibly, planar screen printed electrodes can be applied. Use of the electrodes in hydrodynamic conditions may be needed. The use of FIA and HPLC for rapid screening of electrode compositions is explained. This provides new insights into these chemically dynamic sensor systems, and into the interaction of organic ionic molecules with surfaces.
Export Options
About this article
Cite this article as:
Nagels J. Luc, Vissers Bert, Bohets Hugo, Everaert Joseph and Robbens Johan, Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization, Current Pharmaceutical Analysis 2009; 5 (2) . https://dx.doi.org/10.2174/157341209788172898
DOI https://dx.doi.org/10.2174/157341209788172898 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perspectives in Genomics The Future of Fungi in ‘omics’ era
Current Genomics Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
Current Gene Therapy Neuroprotective Gene Therapy for Parkinson’s Disease
Current Gene Therapy SV40 and HIV Sequences in the Cerebrospinal Fluid of a Patient with AIDS Dementia Complex
Current HIV Research Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Current Pharmaceutical Design Ribosome-inactivating Proteins from Root Tubers and Seeds of Trichosan-thes kirilowii and Other Trichosanthes Species
Protein & Peptide Letters Virus, Oncolytic Virus and Human Prostate Cancer
Current Cancer Drug Targets Antimicrobial Agents Deriving from Indigenous Plants
Recent Patents on Food, Nutrition & Agriculture PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
Endocrine, Metabolic & Immune Disorders - Drug Targets RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
Current Pharmaceutical Biotechnology Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists
Current Drug Metabolism The Role of α7 Nicotinic Acetylcholine Receptors and α7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease
Current Pharmaceutical Design Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Erythropoietin and Wnt1 Govern Pathways of mTOR, Apaf-1, and XIAP in Inflammatory Microglia
Current Neurovascular Research Lymphocytic Choriomeningitis Virus Infection: Neglected Teratogenic Zoonosis
Current Women`s Health Reviews AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) The Role of T-Helper Cells in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Impairment of T Cell Immunity by the Respiratory Syncytial Virus: Targeting Virulence Mechanisms for Therapy and Prophylaxis
Current Medicinal Chemistry Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents